Physician profile
Brooke Smith
NPI 1043955107
$1,956.09
in general payments reported to CMS, 2019-2025
15 companies · $782 in 2025
The $782 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $76.92 · 2023: $489 · 2024: $609 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,879.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $836.92 | 2022-2025 | Lifevest |
| Edwards Lifesciences Corporation | $254.78 | 2022-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $245.29 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $198.50 | 2023-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $82.04 | 2024 | |
| Pfizer INC. | $72.06 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $68.97 | 2023-2024 | Brilinta |
| Janssen Pharmaceuticals, INC | $55.34 | 2023-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.79 | 2024 | Jardiance |
| Vital Connect, INC | $21.38 | 2025 | Vitalpatch Rtm |
| Amgen INC. | $19.16 | 2024 | Repatha |
| Cvrx, INC. | $17.49 | 2023 | Barostim Neo System |
| Atricure, INC. | $16.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.74 | 2024 | |
| Inspire Medical Systems, INC. | $15.73 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.